Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00183898
Status:
UNKNOWN
Last Update Posted:
2019-05-16
First Post:
2005-09-09
Brief Title:
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
Sponsor:
University of Southern California
Organization:
University of Southern California
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2013-02-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-28
Completion Date Type:
ESTIMATED
First Submit Date:
2005-09-09
First Submit QC Date:
September 9 2005
Study First Post Date:
2005-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-14
Last Update Post Date:
2019-05-16
Last Update Post Date Type:
ACTUAL